Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

The pathogenesis of AIDS: lessons learned from other medical conditions.

Griffiths PD, Whitley RD.

Infect Agents Dis. 1996 Oct;5(4):231-9. Review. No abstract available.

PMID:
8884368
2.

Antiviral therapy in the immunocompromised patient.

Prentice HG, Hann IM.

Br Med Bull. 1985 Oct;41(4):367-73. Review. No abstract available.

PMID:
2996686
3.

[Pathogenesis and therapy of persistent infections associated with immunodeficiency syndromes].

Votiakov VI, Kolomiets AG.

Klin Med (Mosk). 1991 May;69(5):29-37. Review. Russian. No abstract available.

PMID:
1649934
4.

Lessons from the Concorde trial.

Gazzard BG.

Br J Hosp Med. 1995 Mar 15-Apr 4;53(6):296. No abstract available.

PMID:
7767581
5.

AIDS: understanding the pathogenesis of HIV infection.

Goldmann DA, Zuck TF.

Infect Control Hosp Epidemiol. 1989 Jun;10(6):248-52. Review. No abstract available.

PMID:
2661680
6.

[Development in and role of antiviral agents].

Lange JM, van der Noordaa J.

Ned Tijdschr Geneeskd. 1992 May 16;136(20):958-64. Review. Dutch. No abstract available.

PMID:
1317510
7.

New AIDS drug passes first clinical test.

Marx JL.

Science. 1989 Jul 28;245(4916):353. No abstract available.

PMID:
2502839
8.

Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir.

Griffiths PD.

J Infect Dis. 2002 Oct 15;186 Suppl 1:S131-7. Review.

PMID:
12353198
9.

AIDS researchers, activists fight crisis in clinical trials.

Nowak R.

Science. 1995 Sep 22;269(5231):1666-7. No abstract available.

PMID:
7569888
10.

Antiviral resistance in clinical practice.

Kimberlin DW, Crumpacker CS, Straus SE, Biron KK, Drew WL, Hayden FG, McKinlay M, Richman DD, Whitley RJ.

Antiviral Res. 1995 Apr;26(4):423-38. Review. No abstract available.

PMID:
7574544
11.

Current leads in antiviral chemotherapy.

De Clercq E.

J Antimicrob Chemother. 1986 Apr;17(4):399-402. Review. No abstract available.

PMID:
3011723
12.

University of Washington AIDS clinical trials unit.

[No authors listed]

STEP Perspect. 1995 Winter;7(3):14-5.

PMID:
11362982
13.

The trials of conducting AIDS drugs trials.

Marx JL.

Science. 1989 May 26;244(4907):916-8. No abstract available.

PMID:
2727685
14.

AIDS drug trials.

Smith R.

Science. 1989 Dec 22;246(4937):1547. No abstract available.

PMID:
2688088
15.

Variant A human herpesvirus six as a cofactor in the pathogenesis of AIDS.

Carrigan DR, Harrington D, Knox KK.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Sep;13(1):97-8. No abstract available.

PMID:
8797694
16.

[A new antiviral substance against AIDS is already tested by phase II trial].

Diehl M.

Dtsch Med Wochenschr. 1996 Jan 5;121(1-2):A21. German. No abstract available.

PMID:
8565798
17.

AIDS drug trials to start amid controversy.

Newmark P.

Nature. 1987 Jun 11-17;327(6122):449. No abstract available.

PMID:
3295563
18.

Resistance of viruses to antiviral drugs.

Freifeld AG, Ostrove JM.

Annu Rev Med. 1991;42:247-59. Review.

PMID:
1852148
19.

[New substance against AIDS in clinical trial].

[No authors listed]

Fortschr Med. 1995 Feb 10;113(4):58. German. No abstract available.

PMID:
7536177
20.

Treatment of HIV infections and AIDS: new horizons.

Koech DK, Obel AO.

East Afr Med J. 1990 Jul;67(7 Suppl 2):SS77-81. Review.

PMID:
2226236

Supplemental Content

Support Center